Sansure Biotech Inc. (SHA:688289)
China
· Delayed Price · Currency is CNY 19.92
-0.15 (-0.75%)
May 14, 2025, 2:44 PM CST
Sansure Biotech Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Cash & Equivalents | 4,399 | - | 4,233 | 3,213 | 2,636 | 2,591 | Upgrade
|
| Trading Asset Securities | 103.59 | - | 548.28 | 2,451 | 2,046 | 1,601 | Upgrade
|
| Cash & Short-Term Investments | 4,503 | 4,569 | 4,782 | 5,664 | 4,683 | 4,192 | Upgrade
|
| Cash Growth | -9.00% | -4.45% | -15.57% | 20.95% | 11.70% | 2433.03% | Upgrade
|
| Accounts Receivable | 732.24 | - | 692.26 | 1,298 | 807.66 | 546.4 | Upgrade
|
| Other Receivables | 59.17 | - | 23.49 | 82.41 | 14.3 | 17.55 | Upgrade
|
| Receivables | 791.4 | - | 715.75 | 1,381 | 821.95 | 563.94 | Upgrade
|
| Inventory | 363.76 | - | 376.63 | 355.31 | 369.5 | 276.74 | Upgrade
|
| Other Current Assets | 118.33 | - | 75.45 | 125.83 | 92.09 | 50 | Upgrade
|
| Total Current Assets | 5,776 | - | 5,950 | 7,525 | 5,966 | 5,083 | Upgrade
|
| Property, Plant & Equipment | 1,256 | - | 1,043 | 785.27 | 481.03 | 216.54 | Upgrade
|
| Long-Term Investments | 623.1 | - | 974.33 | 657.43 | 513.23 | 102.51 | Upgrade
|
| Goodwill | 770.81 | - | 7.66 | - | - | - | Upgrade
|
| Other Intangible Assets | 516.34 | - | 283.28 | 79.12 | 45.55 | 31.23 | Upgrade
|
| Long-Term Deferred Tax Assets | 75.83 | - | 73.82 | 69.62 | 25 | 17.22 | Upgrade
|
| Long-Term Deferred Charges | 148.89 | - | 97.05 | 46.7 | 16.26 | 4.16 | Upgrade
|
| Other Long-Term Assets | 517.58 | - | 25.16 | 10.19 | 43.08 | - | Upgrade
|
| Total Assets | 9,684 | - | 8,454 | 9,174 | 7,090 | 5,454 | Upgrade
|
| Accounts Payable | 434.04 | - | 271.14 | 586.26 | 188.82 | 208.05 | Upgrade
|
| Accrued Expenses | 103.21 | - | 363.33 | 622.39 | 231.82 | 237.88 | Upgrade
|
| Short-Term Debt | 18 | - | 9 | - | - | 55 | Upgrade
|
| Current Portion of Leases | 5.06 | - | 11.1 | 14.26 | 8.49 | - | Upgrade
|
| Current Income Taxes Payable | 21.83 | - | 17.66 | 145.25 | 80.16 | 104.17 | Upgrade
|
| Current Unearned Revenue | 41.18 | - | 32.81 | 53.11 | 78.64 | 62.47 | Upgrade
|
| Other Current Liabilities | 677.93 | - | 214.12 | 150.45 | 76.01 | 21.11 | Upgrade
|
| Total Current Liabilities | 1,301 | - | 919.15 | 1,572 | 663.93 | 688.69 | Upgrade
|
| Long-Term Leases | 11.44 | - | 18.21 | 13.6 | 6.41 | - | Upgrade
|
| Long-Term Unearned Revenue | 38.19 | - | 32.49 | 30.53 | 25.68 | 18.95 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 90.38 | - | 59.45 | 19.04 | 13.01 | 1.31 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 26.09 | - | - | Upgrade
|
| Total Liabilities | 2,251 | - | 1,029 | 1,661 | 709.03 | 708.95 | Upgrade
|
| Common Stock | 579.39 | - | 588.46 | 588.46 | 400 | 400 | Upgrade
|
| Additional Paid-In Capital | 1,602 | - | 1,908 | 1,914 | 2,065 | 2,055 | Upgrade
|
| Retained Earnings | 5,286 | - | 5,177 | 5,371 | 4,082 | 2,288 | Upgrade
|
| Treasury Stock | -164.89 | - | -515.33 | -392.6 | -200.01 | - | Upgrade
|
| Comprehensive Income & Other | 39.17 | - | 43.26 | 19.36 | 21.71 | 2.12 | Upgrade
|
| Total Common Equity | 7,341 | 7,238 | 7,201 | 7,501 | 6,369 | 4,745 | Upgrade
|
| Minority Interest | 91.46 | - | 223.64 | 12.16 | 12.43 | - | Upgrade
|
| Shareholders' Equity | 7,433 | 7,353 | 7,425 | 7,513 | 6,381 | 4,745 | Upgrade
|
| Total Liabilities & Equity | 9,684 | - | 8,454 | 9,174 | 7,090 | 5,454 | Upgrade
|
| Total Debt | 844.66 | 435.52 | 38.31 | 27.86 | 14.9 | 55 | Upgrade
|
| Net Cash (Debt) | 3,658 | 4,133 | 4,743 | 5,636 | 4,668 | 4,137 | Upgrade
|
| Net Cash Growth | -19.11% | -12.86% | -15.83% | 20.74% | 12.83% | 2399.80% | Upgrade
|
| Net Cash Per Share | 6.23 | 7.02 | 8.09 | 9.63 | 7.93 | 7.49 | Upgrade
|
| Filing Date Shares Outstanding | 574.18 | 630.43 | 573.52 | 578.69 | 592 | 592 | Upgrade
|
| Total Common Shares Outstanding | 574.18 | 630.43 | 572.21 | 578.69 | 592 | 592 | Upgrade
|
| Working Capital | 4,475 | - | 5,030 | 5,954 | 5,302 | 4,394 | Upgrade
|
| Book Value Per Share | 12.79 | 12.62 | 12.59 | 12.96 | 10.76 | 8.02 | Upgrade
|
| Tangible Book Value | 6,054 | 6,887 | 6,910 | 7,421 | 6,323 | 4,714 | Upgrade
|
| Tangible Book Value Per Share | 10.54 | 12.00 | 12.08 | 12.82 | 10.68 | 7.96 | Upgrade
|
| Buildings | - | - | 826.53 | 344.51 | 231.04 | 177.15 | Upgrade
|
| Machinery | - | - | 436.62 | 322.65 | 270.13 | 142.76 | Upgrade
|
| Construction In Progress | - | - | 4.59 | 267.76 | 110.45 | 1.85 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.